Related Experiment Videos
Chronic fatigue syndrome: what factors trigger it off?
Clinical and Experimental Rheumatology
|September 1, 1994
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gated liquid scintillator detector for neutron time of flight measurements in a gas-puff Z-pinch experiment.
The Review of scientific instruments·2019
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
Arthritis research & therapy·2019
Outcome and risk factors for progression in IgG4-related disease under watchful waiting.
Clinical and experimental rheumatology·2026
Safety and procedural success of minor salivary gland biopsy in Sjögren's disease: a retrospective analysis of 202 patients.
Clinical and experimental rheumatology·2026
AI-augmented rheumatologist? Reflections on AI-induced technostress, job insecurity and professional identity.
Clinical and experimental rheumatology·2026
The role of phospholipase D4 in inflammatory autoimmune diseases.
Clinical and experimental rheumatology·2026
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms.
Clinical and experimental rheumatology·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026